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Abstract 
People need reliable information regarding over-the-counter medications (OTCs), so that they can independently 
make appropriate informed choices. The study aimed to identify the information providers and channels that have an 
impact on the purchase of OTCs, and to demonstrate the information needs of OTC purchasers, using these providers 
and channels, from the viewpoint of information characteristics such as specialty, objectivity, concreteness, compre-
hensiveness, individuality, and availability, focusing on the efficacy of OTCs and related safety information. A question-
naire survey of randomly sampled adults aged ≥20 was conducted at the Japan Drugstore Show 2012, hosted by the 
Japan Association of Chain Drug Stores. In this questionnaire, information was particularly limited to the efficacy and 
safety of OTCs. Multivariate logistic regression analysis was performed on data from 1743 respondents (1625 purchas-
ers and 118 non-purchasers of OTCs) who obtained information on OTCs in their daily lives, to demonstrate the asso-
ciations between the use of information providers and channels (predictor variables) and the purchase of OTCs (out-
come variable), as well as between information characteristics valued by purchasers (predictor variables) and their use 
of these information providers or channels (outcome variables). Both the use of pharmacists as information providers 
and consultation at pharmacies as an information channel were positively associated with the purchase of OTCs 
(odds ratio [OR], 3.74; 95 % confidence interval [CI], 2.46–5.68; P < 0.001 and OR, 4.55; 95 % CI 2.92–7.11, P < 0.001, 
respectively), whereas both the use of family or friends using OTCs as information providers and family or friends as 
information channels were negatively associated with the purchase of OTCs (OR, 0.60; 95 % CI 0.40–0.90; P = 0.014 
and OR, 0.55; 95 % CI 0.36–0.82; P = 0.004, respectively). OTC purchasers who valued individuality of information were 
more likely to use pharmacists (OR 2.00; 95 % CI 1.61–2.48; P < 0.001) and consultation at pharmacies (OR 1.98; 95 % 
CI 1.61–2.43; P < .001). In conclusion, individualized information provided by pharmacists on the efficacy and safety of 
OTCs during consultation at pharmacies can play the most important role in the informed choices of OTC purchasers.
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Background
Self‑medication in Japan
During the 20th century, along with socioeconomic 
development, lifestyle related diseases became the major 
cause of death in Japan and other advanced countries 
(The Ministry of Health, Labour and Welfare [MHLW] 
2015). Consequently, the promotion of public health 
became an important issue for Japan (MHLW 2002a). 
Against this backdrop, the MHLW initiated “Healthy 
Japan 21” in March 2001, and the “Health Promotion 
Act” in August 2002 (MHLW 2002a; Sakurai 2003). These 
initiatives promulgated that people should have a duty to 
promote their own health. Along with changes in disease 
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structure such as increase of adult diseases by progres-
sion of aging, repercussion of informed consent and pur-
suit of quality of life (QOL), more Japanese have become 
conscious of their health and medical care (MHLW 
2007). “Self-care” that people do for themselves to estab-
lish and maintain health, prevent and deal with illness 
(The World Health Organization [WHO] 1998), and fur-
thermore, “self-medication” that people select and use 
medicines by themselves to treat self-recognized illnesses 
or symptoms began to spread through the Japanese peo-
ple (MHLW 2007). Currently, self-medication is a wide-
spread practice in Japan (Shaku et al. 2015). With a view 
of improving the efficient use of medical resources, the 
MHLW released a report on the expected role of OTCs 
in self-medication in November 2002 (MHLW 2002b), 
which stated that broader use of OTCs should be recom-
mended in self-medication, and that their role should 
include not only the treatment of minor diseases, but also 
prevention of diseases, early treatment of diseases, pre-
vention of disease exacerbation, and self-examination of 
health status. Table  1 shows the recent legislative/non-
legislative changes related to OTCs in Japan. Among var-
ious self-medication options, the use of OTCs is the most 
prevalent (Aoyama et al. 2012). In Japan, OTCs are clas-
sified into four categories, according to their risk levels: 
OTCs requiring guidance (post-marketing safety evalua-
tion is incomplete), first-class OTCs (especially high risk), 
second-class OTCs (relatively high risk), and third-class 
OTCs (others). Consumers can purchase all the OTC cat-
egories at OTC pharmacies and out-of-hospital dispens-
ing pharmacies; first-, second, and third-class OTCs at 
online pharmacies; and third-class OTCs at convenience 
stores and supermarkets. Recent market trends for OTCs 
in Japan have proven sluggish. In 2013, the market had 
shown a slight, 1.6  % growth (614 billion yen; Fuji Kei-
zai 2014) since 2012 (604.3 billion yen), although it had 
decreased by 2.2  % since 2008 (627.7 billion yen; Fuji 
Keizai 2009). In contrast, the market for switch-OTCs in 
Japan, which had been 137.5 billion yen in 2005, reached 
150 billion yen in 2011, and has been on an expansionary 
trend since then (Fuji Keizai 2015). The Japanese Pharma-
ceutical Affairs Law was revised in 2013; a new category 
was added to the OTC risk categories, “OTCs requiring 
guidance,” into which new switch-OTCs are classified. 
This revision of the trading system of OTCs would accel-
erate the switching of prescription drugs to OTCs. The 
market for switch-OTCs in Japan was expected to reach 
162 billion yen in 2014, and to continue growing beyond 
2015 (Fuji Keizai 2015).
Consumers’ attitudes toward information on OTCs
With regard to OTCs, consumers tended to require effi-
cacy (Sasaki et al. 2008; Tokyo metropolitan government 
2011) and safety information (MHLW 1997; Mutebi et al. 
2013; Raynor et al. 2007; Wazaify et al. 2005), more than 
any other information. OTC manufacturers indicate 
the efficacy and safety information of OTC products on 
their packages; however, a large number of people did 
not pay attention to written information accompanying 
medicines (Raynor et al. 2007). An eye-movement study 
revealed that Japanese consumers paid less attention to 
risk information appearing on the packages of OTCs than 
did Americans (Kawase et al. 2012). Pharmacies were the 
most common place for individuals to obtain information 
on OTC products (Eichenberg et al. 2015). Japanese con-
sumers tended to want to consult with pharmacists when 
they purchased OTCs at pharmacies (Aoyama et al. 2012; 
Sasaki et al. 2008). These findings indicated that consum-
ers might obtain information on the efficacy and safety 
of OTCs from information sources other than the OTC 
packages or other written instructions, perhaps from 
pharmacists at pharmacies.
Aims of the study
The study aimed to identify information providers and 
channels of the efficacy and safety information of OTCs, 
that ultimately had an impact on Japanese consumers’ 
purchase of OTCs. The study also intended to reveal the 
Table 1 Recent legislative/non-legislative changes related to OTCs in Japan
OTC over-the-counter medication
Year Recent legislative/non‑legislative changes related to OTCs in Japan
2002 An online chain OTC pharmacy initiated online sales of OTCs
2009 OTCs were classified into 3 categories, according to their risk levels: first-class OTCs (especially high risk), second-class OTCs (relatively high risk), 
and third-class OTCs (others)
The online sale of first- and second-class OTCs was prohibited
The registered distributor qualification system was enforced
Two online chain OTC pharmacies filed a lawsuit against the government, arguing for the ban on online OTC sales to be lifted
2013 The Supreme Court ruled that the ban on online OTC sales was illegal and, thus, invalid
2014 A new risk category (OTCs requiring guidance [post-marketing safety evaluation is incomplete]) was added to the OTC classification
The online sale of all OTCs, except those requiring guidance, was officially permitted
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information needs of OTC purchasers presenting at every 
information provider and channel, from the viewpoint 
of the following information characteristics, instead of 
information content: specialty, objectivity, concreteness, 
comprehensiveness, individuality, and availability, and 
then discussed appropriate methods of information pro-




1872 subjects responded to the questionnaires; a 
response rate of 93.6  % was achieved within a day. Of 
these individuals, 1743 completed the questionnaires. All 
of them indicated in the questionnaire that they obtained 
information regarding OTCs in their daily lives, and their 
data formed the basis of the analyses in this paper; 1625 
(93.2 %) purchased OTCs in their daily lives (purchasers), 
and 118 (6.8 %) did not (non-purchasers).
Information providers and the purchase of OTCs
Table 2 shows the associations between the use of infor-
mation providers and the purchase of OTCs. The use 
of pharmacists as information providers was positively 
associated with the purchase of OTCs (odds ratios [ORs] 
3.74; 95  % confidence interval [95  % CI] 2.46–5.68; 
P < 0.001), while the use of family or friends using OTCs 
was negatively associated with OTC purchase (OR 0.60; 
95  % CI 0.40–0.90; P  =  0.014). The utilization rate of 
OTCs among non-purchasers who used family or friends 
using OTCs as information providers was 71 % (data not 
shown).
Valuable information characteristics and information 
providers
Among OTC purchasers, the proportions of those who 
considered concreteness, individuality, objectivity, avail-
ability, specialty, and comprehensiveness to be valuable 
for information on OTCs were 65.8, 45.8, 39.9, 32.7, 32.2, 
and 13.2  %, respectively (data not shown). Among the 
13 information providers investigated, the five informa-
tion providers used most often by OTC purchasers were 
pharmacists, OTC manufacturers, family or friends using 
OTCs, medical doctors, and ordinary users (utilization 
rate: 65.2, 60.8, 53.5, 44.7, and 26.6 %, respectively; data 
not shown). Table  3 shows the associations between 
information characteristics valued and the use of these 
five information providers in OTC purchasers. Those 
who considered specialty to be valuable for information 
on OTCs were more likely to use OTC manufacturers, 
medical doctors, or ordinary users of OTCs (OR, 1.50; 
Table 2 Associations between the use of information pro-
viders and the purchase of OTCs
The outcome and predictor variables were the purchase of OTCs (Yes/No) and 
the use of each information provider (Yes/No), respectively
CI confidence interval, OR odds ratio, OTC over-the-counter medication
a n = 1743
b Variables were mutually adjusted
c Statistically significant (P < 0.05)
Information provider (used: yes/no) Multivariate logistic regres‑
sion analysisa
ORb (95 % CI) P‑valuec
Pharmacists
 Yes 3.74 (2.46, 5.68) <0.001
 No 1.00 [Reference]
OTC manufacturers
 Yes 1.13 (0.76, 1.67) 0.549
 No 1.00 [Reference]
Family or friends using OTCs
 Yes 0.60 (0.40, 0.90) 0.014
 No 1.00 [Reference]
Medical doctors
 Yes 0.77 (0.51, 1.17) 0.220
 No 1.00 [Reference]
Ordinary users of OTCs
 Yes 1.42 (0.87, 2.32) 0.157
 No 1.00 [Reference]
Public organizations
 Yes 1.07 (0.62, 1.83) 0.806
 No 1.00 [Reference]
Nurses
 Yes 1.09 (0.60, 1.98) 0.769
 No 1.00 [Reference]
Salespersons
 Yes 0.87 (0.45, 1.68) 0.682
 No 1.00 [Reference]
Mass communications
 Yes 1.80 (0.88, 3.69) 0.107
 No 1.00 [Reference]
Registered distributors
 Yes 1.59 (0.66, 3.82) 0.298
 No 1.00 [Reference]
Public health nurses
 Yes 0.51 (0.25, 1.02) 0.058
 No 1.00 [Reference]
OTC experts
 Yes 1.14 (0.42, 3.08) 0.803
 No 1.00 [Reference]
People of learning and experience
 Yes 0.66 (0.26, 1.69) 0.383
 No 1.00 [Reference]
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95  % CI 1.20–1.88; P  <  0.001, OR, 2.12; 95  % CI 1.71–
2.64; P < 0.001, or OR 1.29; 95 % CI 1.01–1.63; P = 0.039, 
respectively) for their information providers. Those 
considering objectivity valuable were more likely to use 
ordinary users of OTCs (OR, 1.57; 95  % CI, 1.25–1.97; 
P  <  0.001); those who considered concreteness valuable 
were more likely to use family or friends using OTCs, 
medical doctors, or ordinary users of OTCs (OR 1.82; 
95 % CI 1.47–2.25; P < 0.001, OR 1.35; 95 % CI 1.09–1.67; 
P  =  0.006, or OR 1.76; 95  % CI 1.37–2.26; P  <  0.001, 
respectively); those who considered comprehensiveness 
valuable were more likely to use OTC manufacturers or 
medical doctors (OR 1.53; 95 % CI 1.12–2.10; P = 0.008 
or OR 1.41; 95 % CI 1.05–1.90; P = 0.024, respectively); 
those who considered individuality valuable were more 
likely to use pharmacists or medical doctors (OR 2.00; 
95 % CI 1.61–2.48; P < 0.001 or OR 1.41; 95 % CI 1.15–
1.73; P  =  0.001, respectively) and unlikely to use OTC 
manufacturers (OR 0.71; 95 % CI 0.58–0.88; P = 0.001); 
and those who considered availability valuable were more 
likely to use OTC manufacturers, family or friends using 
OTCs, or ordinary users of OTCs (OR 1.27; 95 % CI 1.02–
1.57; P = 0.033, OR 1.46; 95 % CI 1.18–1.80; P = 0.001, or 
OR 1.73; 95 % CI 1.37–2.18; P < 0.001, respectively).
Information channels and the purchase of OTCs
Table 4 shows the associations between the use of infor-
mation channels and the purchase of OTCs. The use of 
consultation at pharmacies as an information channel 
was positively associated with the purchase of OTCs (OR 
4.55; 95 % CI 2.92–7.11; P < 0.001), while the use of fam-
ily or friends was negatively associated with the purchase 
of OTCs (OR 0.55; 95  % CI 0.36–0.82; P =  0.004). The 
utilization rate of OTCs among non-purchasers who 
used family or friends as information channels was 70 % 
(data not shown).
Valuable information characteristics and information 
channels
Among the 10 information channels investigated, OTC 
purchasers used consultation at pharmacies, family or 
friends, the Internet, consultation at medical institu-
tions, and TV or radio as the five most used informa-
tion channels (utilization rate: 55.9, 53.4, 42.8, 42.4, and 
42.0 %, respectively; data not shown). Table 5 shows the 
associations between information characteristics val-
ued and the use of these five information channels in 
OTC purchasers. Those who considered specialty valu-
able for information on OTCs were more likely to use 
the Internet or consultation at medical institutions (OR 
1.95; 95 % CI 1.57–2.42; P < 0.001 or OR 1.75; 95 % CI 
1.41–2.17; P  <  0.001, respectively), and unlikely to use 
consultation at pharmacies (OR 0.79; 95 % CI 0.64–0.98; 
P  =  0.030) for their information channels. Those who 
considered objectivity valuable were more likely to use 
family or friends, the Internet, or consultation at medi-
cal institutions (OR 1.23; 95 % CI 1.00–1.51; P = 0.047, 
OR 1.38; 95 % CI 1.12–1.70; P = 0.002, or OR 1.29; 95 % 
CI 1.05–1.59; P = 0.014, respectively). Those who consid-
ered concreteness valuable were more likely to use fam-
ily or friends, the Internet, or television (TV) or radio 
(OR 1.81; 95  % CI 1.46–2.23; P  <  0.001, OR 1.59; 95  % 
Table 4 Associations between  the use of  information 
channels and the purchase of OTCs
The outcome and predictor variables were the purchase of OTCs (Yes/No) and 
the use of each information channel (Yes/No), respectively
CI confidence interval, OR odds ratio, OTC over-the-counter medication
a n = 1743
b Variables were mutually adjusted
c Statistically significant (P < 0.05)
Information channel (used: yes/no) Multivariate logistic regres‑
sion analysisa
ORb (95 % CI) P‑valuec
Consultation at pharmacies
 Yes 4.55 (2.92, 7.11) <0.001
 No 1.00 [Reference]
Family or friends
 Yes 0.55 (0.36, 0.82) 0.004
 No 1.00 [Reference]
Internet
 Yes 1.29 (0.86, 1.93) 0.213
 No 1.00 [Reference]
Consultation at medical institutions
 Yes 0.94 (0.63, 1.39) 0.750
 No 1.00 [Reference]
TV or radio
 Yes 1.05 (0.70, 1.59) 0.809
 No 1.00 [Reference]
Newspapers or advertising inserts
 Yes 0.74 (0.47, 1.16) 0.189
 No 1.00 [Reference]
Packages or package leaflets
 Yes 1.02 (0.63, 1.64) 0.943
 No 1.00 [Reference]
Books or magazines
 Yes 1.48 (0.72, 3.04) 0.293
 No 1.00 [Reference]
Customer services of OTC manufacturers
 Yes 0.93 (0.48, 1.80) 0.838
 No 1.00 [Reference]
Consultation services of public organizations
 Yes 1.14 (0.53, 2.46) 0.734
 No 1.00 [Reference]
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CI 1.28–1.97; P < 0.001, or OR 1.26; 95 % CI 1.02–1.56; 
P =  0.036, respectively), whereas those who considered 
individuality valuable were more likely to use consulta-
tion at pharmacies or at medical institutions (OR 1.98; 
95 % CI 1.61–2.43; P < 0.001 or OR 1.51; 95 % CI 1.23–
1.85; P < 0.001, respectively), and unlikely to use TV or 
radio (OR 0.72; 95 % CI 0.59–0.88; P = 0.002). Those who 
considered availability valuable were more likely to use 
family or friends, the Internet, or TV or radio (OR 1.44; 
95  % CI 1.16–1.78; P =  0.001, OR 1.56; 95  % CI 1.28–




As far as we know, the current study is the first investiga-
tion to reveal the information needs of Japanese consum-
ers regarding the efficacy and safety of OTCs by focusing 
on the features of the information rather than the infor-
mation content. As mentioned above, with regard to 
OTCs, several previous studies have investigated the 
information sources that they used throughout their pur-
chasing behavior. The current study focused on the step 
at which consumers chose and purchased specific OTCs 
based on certain information, seeking to address the fol-
lowing questions: (1) Did pharmacists as information 
providers and consultation at pharmacies as an infor-
mation channel ultimately influence consumers’ choices 
regarding the purchase of specific OTCs? (2) What about 
other information providers and channels? (3) What 
information characteristics did consumers expect from 
their information providers and channels with regard to 
OTCs? The study identified information providers and 
channels that ultimately had an impact on the purchase 
of OTCs by Japanese consumers; one of the distinctive 
features of this study was that it investigated informa-
tion sources by dividing them into information provid-
ers and channels. Information providers, each bringing 
different levels of credibility and expertise, should pro-
vide consumers with sufficient information to meet their 
information needs in order to give significant support to 
their informed choices regarding OTCs. The study also 
revealed the information needs of OTC purchasers at 
every information provider and channel they used, from 
the viewpoint of the features of the information.
Key information providers, channels and characteristics
Using descriptive statistics, previous studies in Ireland 
(Wazaify et  al. 2005) and in Japan (Aoyama et  al. 2012) 
demonstrated that recommendations by pharmacists 
most frequently influenced consumers’ choice of OTCs. 
The current study obtained similar results, using inferen-
tial statistics. It demonstrated that information provided 
by pharmacists had a positive impact on Japanese con-
sumers’ purchase of OTCs. As for information channels, 
a nationwide representative survey in Germany (Eichen-
berg et al. 2015) reported pharmacies to be the most com-
mon place from which consumers obtained information 
about OTCs. This survey, however, indicated neither the 
information channel (e.g., consultation and product pack-
ages) utilized by consumers at pharmacies nor whether 
or not the information obtained at pharmacies had an 
actual impact on consumers’ choices regarding the pur-
chase of specific OTCs. The current study revealed that 
consultation at pharmacies was the most commonly used 
information channel for OTC purchasers, and that the 
information provided through this channel had a positive 
impact on consumers’ purchase of OTCs. A published 
systematic review (Raynor et al. 2007) reported interest-
ing results. Most patients did not value the written infor-
mation on medicines, which manufacturers had prepared 
according to strict regulations; however, they valued the 
information if it was tailored to their individual circum-
stances and illness. The findings indicated that patients 
typically required individualized, rather than statutory 
information, when they used such information for deci-
sion-making. The current study obtained similar results; 
OTC purchasers who used pharmacists as information 
providers and who used consultation at pharmacies as an 
information channel were more likely to value individual-
ized information than were purchasers who did not use 
them. These findings indicate that it may be preferable 
for pharmacists to provide OTC purchasers mainly with 
information tailored to their individual conditions, con-
stitution, lifestyles, and so on, during their consultation 
at pharmacies. The study also revealed that OTC pur-
chasers who used consultation at pharmacies were less 
likely to require specialized information, suggesting that 
during consultation at pharmacies, purchasers should be 
provided mainly with individualized information, rather 
than specialized information containing scientific knowl-
edge, such as action mechanisms of active ingredients of 
OTCs. OTC purchasers who needed specialized informa-
tion were more likely to use other information channels, 
such as the Internet and medical institutions.
Family or friends using OTCs as information providers 
and family or friends as information channels
This study also revealed that the information provided by 
family or friends using OTCs and the information pro-
vided through family or friends had a negative impact on 
consumers’ purchase of OTCs. The vast majority of non-
purchasers who used such information, however, utilized 
OTCs, indicating that perhaps they entrusted the pur-
chase of OTCs that they needed to someone else, rather 
than that some negative information provided by family 
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or friends using OTCs or through family or friends made 
them give up purchasing OTCs. This “entrustment of pur-
chasing OTCs” may be the source of the negative impact 
on the purchase of OTCs mentioned above. Family or 
friends using OTCs made up one of the five information 
providers used most often by OTC purchasers, and those 
who valued the concreteness or availability of information 
tended to use those information providers, rather than 
pharmacists. We assume that OTC purchasers might use 
family or friends using OTCs as information providers, 
when they want to know the efficacy and safety of OTCs 
actually and personally experienced by the latter, instead of 
general explanations. They may also use these individuals 
when they want to know concrete features of OTCs, such 
as the shape, size, taste, and smell thereof, and the ease 
with which OTCs can be swallowed, along with the effi-
cacy and safety of OTCs; when they want to know the effi-
cacy and safety of household OTCs; or when they quickly 
want some reference information, before getting individu-
alized information from pharmacists at pharmacies.
Registered distributors as information providers
Like pharmacists, registered distributors, who are quali-
fied to sell second- and third-class OTCs, have opportu-
nities to come face-to-face with OTC purchasers, and to 
have two-way communication with them at pharmacies; 
however, information provided by them didn’t have sig-
nificant impact on their purchase of OTCs. The registered 
distributor system was enforced in 2009, so, perhaps that 
system was not well-recognized by OTC purchasers at 
the time of the survey; a 2011 survey in Tokyo, Japan 
(Tokyo metropolitan government 2011), reported that 
more than half of the OTC purchasers investigated did 
not know the registered distributor system.
Medical doctors as information providers
Medical doctors can provide people with face-to-face 
two-way communication mainly at medical institutions, 
and just like pharmacists, they tended to be used by OTC 
purchasers who considered individuality a valuable infor-
mation characteristic; however, information provided by 
them didn’t have significant impact on consumers’ pur-
chase of OTCs. Although OTC purchasers who valued 
various information characteristics as well as individu-
ality were more likely to use medical doctors, informa-
tion provided by them, even individualized information, 
might not have had enough influence to lead people to 
purchase OTCs. A Patient Attitude Questionnaire in the 
West Midlands (Bradley et  al. 1998) demonstrated that 
patients generally expressed positive attitudes regarding 
their doctors’ suggestions to try OTCs. It is probable that 
medical doctors might have an impact on consumers’ 
decisions to substitute prescription drugs with OTCs.
Consultation at medical institutions as an information 
channel
Consultation at medical institutions can provide people 
with face-to-face two-way communication with medi-
cal personnel, and can provide them with individualized 
information; indeed, OTC purchasers who considered 
individuality to be a valuable information characteristic 
were more likely to use this information channel. How-
ever, information provided through consultation at medi-
cal institutions, even individualized information, didn’t 
have a significant impact on their purchase of OTCs. 
Combining these findings with those of the analyses 
focusing on pharmacists, medical doctors and consulta-
tion at pharmacies described above, it may be concluded 
that the purchase of OTCs is driven by “individualized 
information” provided by “face-to-face two-way commu-
nication” “at sites selling OTCs.”
The Internet as an information channel
The results of the study demonstrated that information 
provided through the Internet didn’t have a significant 
impact on the purchase of OTCs. Those respondents who 
used the Internet for OTC purchases were more likely to 
require specialized, objective, concrete, or easily available 
information rather than individualized information at the 
time of the survey, indicating that the Internet served as 
a one-way communication tool to obtain general infor-
mation. The Japanese Pharmaceutical Affairs Law was 
revised in June 2014, following which the online sale of 
most OTCs was officially permitted. The removal of the 
ban on online sales should enhance consumers’ conveni-
ence in purchasing OTCs. A previous survey in Germany 
(Holtgräfe and Zentes 2012) reported that the preferred 
use of the Internet as an OTC information source posi-
tively influenced the use of online pharmacies as pur-
chase channels for OTCs. The current study showed 
that nearly half of OTC purchasers used the Internet as 
an information channel, and a questionnaire survey of 
Japanese consumers (Nakao et  al. 2015) reported that 
3.8 % of consumers used online pharmacies following the 
lifting of the ban on online sales. Taken together, these 
findings suggest that more consumers would use online 
pharmacies in the near future. When the survey was con-
ducted, the utilization rate of the Internet as an informa-
tion channel for OTCs was significantly lower than that 
of consultation at pharmacies. With the popularization of 
Internet OTC sales, purchasers’ use of online information 
will only increase, and the Internet will become a more 
important information channel in addition to function-
ing as a purchasing channel. Furthermore, it’s possible 
that the characteristics of Internet information sought 
by OTC purchasers might change; they might request 
online pharmacies to provide them with individualized 
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information through two-way communication to make 
informed choices regarding OTCs.
TV or radio as an information channel
TV or radio is a convenient information channel, and 
OTC purchasers who used them were more likely to 
value availability of information rather than individual-
ity. TV or radio, however, did not have enough influence 
to lead consumers to purchase OTCs. We assume that 
information obtained through TV or radio, especially 
product commercials, would play a role in making con-
sumers aware of OTC products, based on a Japanese 
questionnaire survey’s report (Aoyama et  al. 2012) that, 
although OTC advertisements had a powerful effect on 
the perceptions of consumers of a low socioeconomic 
status, consumers did not rely solely on the information 
garnered from such advertisements, when choosing a 
product.
The findings of the current study also suggest that the 
information characteristics required by OTC purchas-
ers differ according to both information providers and 
channels.
Limitations of the study
The limitations of the study included the representative-
ness of the study subjects. OTC purchasers were in the 
majority. Most of the subjects could have been residents 
of a metropolitan area, and some subjects could have 
used OTC pharmacies (so-called “drugstores”) relatively 
more often because the study subjects were the visitors 
at the Japan Drugstore Show 2012, held in Chiba Prefec-
ture. We, however, did not think that the study setting 
had a major influence on our findings, because Japanese 
consumers generally purchased OTCs at OTC pharma-
cies, as reported by several consumer surveys in Japan 
(MyVoice Co., Inc. 2012; Tokyo metropolitan govern-
ment 2011; Tachi et al. 2015). An earlier survey study in 
Japan reported that more than half of high school stu-
dents who used OTCs utilized them by their own deci-
sion (Anraku et al. 2011). As the current study included 
subjects aged ≥20, it is necessary to include younger 
people in the study sample to investigate their in situ use 
of information for OTCs. Another limitation was that 
the study didn’t consider consumers’ non-demographic/
lifestyle factors that could influence their purchasing of 
OTCs. Associations between consumers’ use of OTCs 
and their non-demographic/lifestyle factors have been 
demonstrated in previous studies (Conn 1991; Morales-
Suárez-Varela et  al. 2009; Villako et  al. 2012). Associa-
tions between consumers’ socioeconomic status and their 
decisions to use either prescription medications or OTCs 
have also been indicated (Aoyama et  al. 2012; Nielsen 
et al. 2003; Sato et al. 2011). Although it is possible that 
some of these factors have a direct or indirect influence 
on consumers’ choices of information providers and 
channels, as well as on their information needs and their 
purchases of OTCs, no study investigating such possibili-
ties has been reported to date. Further study should be 
conducted considering consumers’ socioeconomic status 
and non-demographic/lifestyle factors that may influence 
their OTC-related behaviour.
Conclusion
This study demonstrated that pharmacists as informa-
tion providers, consultation at pharmacies as an infor-
mation channel, and the individualized information they 
provided played an important role in OTC purchasers’ 
informed choices about OTCs. Moreover, key informa-
tion characteristics for OTC purchasers differed accord-
ing to information providers and channels. The findings 
give information providers a useful clue to distribute 
more appropriate information that may facilitate con-
sumers to make more informed choices regarding OTCs 
through suitable information channels.
Methods
Questionnaire
A self-developed questionnaire was prepared; it included 
respondents’ demographic information, such as gender 
and age, the purchase and utilization of OTCs, and the 
following questions: (1) Among the information provid-
ers below, which do you usually use to obtain informa-
tion on OTCs? (2) Among the information channels 
below, which do you usually use to obtain information 
on OTCs? and (3) Among the information characteristics 
below, which do you consider valuable for information on 
OTCs? In this questionnaire, “information” was particu-
larly limited to the efficacy and safety of OTCs. Thirteen 
information sources and 10 information channels were 
investigated. The information sources were OTC manu-
facturers, public organizations (e.g. MHLW, local health 
authorities), ordinary users of OTCs, family or friends 
using OTCs, mass communications, OTC experts, peo-
ple of learning and experience (e.g. professors, academic 
researchers), medical doctors, pharmacists, registered 
distributors, nurses, public health nurses, and salesper-
sons. The information channels were customer services 
of OTC manufacturers, consultation services of public 
organizations, consultation at pharmacies, the Inter-
net, consultation at medical institutions, TV or radio, 
newspapers or advertising inserts, books or magazines, 
packages or package leaflets, and family or friends. For 
information characteristics, 6 properties were defined: 
“specialty” (specialized information about OTCs, includ-
ing scientific knowledge such as action mechanisms of 
active ingredients), “objectivity” (fact-based scientific 
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and objective information furnished by non-stakehold-
ers), “concreteness” (concrete features of OTCs based on 
users’ real-life experience), “comprehensiveness” (infor-
mation that covers a wide range of knowledge of every 
OTC product), “individuality” (information tailored to 
consumers’ individual conditions, constitution, lifestyles 
and so on), and “availability” (information easily obtained 
at any time and place).
Execution of a questionnaire survey
A face-to-face, self-completed questionnaire survey was 
conducted at the Japan Drugstore Show 2012 on March 
17, 2012 at Makuhari in Chiba Prefecture, Japan. The 
annual Japan Drugstore Show, hosted by the Japan Asso-
ciation of Chain Drug Stores, is one of the biggest exhi-
bitions of healthcare in Asia with more than 120,000 
visitors. 2000 questionnaires were randomly distributed 
to the visitors aged ≥20, who filled them out anony-
mously. The filled-out questionnaires were collected on 
the same day. Respondents who answered all the ques-
tions were identified as valid respondents. Among these, 
those who indicated in the questionnaires that they did 
not obtain information regarding OTCs in their daily 
lives were excluded from the analysis.
Statistical analyses
Multivariate logistic regression analyses were performed 
to evaluate associations between the use of information 
providers or channels and the purchase of OTCs; the 
outcome and predictor variables were the purchase of 
OTCs (Yes/No) and the use of each information provider 
or channel (Yes/No), respectively. Next, the relationship 
between OTC purchasers’ valuing of OTC information 
characteristics and their use of each information provider 
or channel was evaluated using the same approach; the 
outcome and predictor variables were the use of each 
information provider or channel (Yes/No) and the valu-
ing of each information characteristic (Yes/No), respec-
tively. The results are presented as estimated ORs with 
respective 95  % CIs and P-values. All statistical evalu-
ations were considered significant if P  <  0.05. The plat-
form for the statistical analyses was Ekuseru-Toukei 2012 
(Social Survey Research Information Co., Ltd.).
Authors’ contributions
MH designed the study, conducted the questionnaire survey, performed the 
statistical analysis and drafted the manuscript. SM participated in the design 
of the study and helped to draft the manuscript. HK participated in the design 
of the study and reviewed the manuscript. All authors read and approved the 
final manuscript.
Acknowledgements
The authors wish to thank Mr. Hyouma Oda, Mr. Mamoru Munakata, Ms. Yoshie 
Watanabe and Mr. Toshiya Shiina of the Japan Association of Chain Drug 
Stores for their cooperation with this survey. The authors also wish to thank 
Prof. Chris D. Beaumont of Global COE Program, Translational Research Initia-
tive, The University of Tokyo for reviewing the manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 1 April 2015   Accepted: 20 November 2015
References
Fuji Keizai Management Co., Ltd. (2009) Non-prescription Drugs Data Book 
2009. Japan
Fuji Keizai Management Co., Ltd. (2014) Non-prescription Drugs Data Book 
2014. Japan
Fuji Keizai Management Co., Ltd. (2015) Non-prescription Drugs Data Book 
2015. Japan
Anraku M, Tomida H, Sato E, Tabuchi N, Yoshitomi H, Okamura N, Taguchi 
K, Kondo Y, Murakami N (2011) Surveillance study on use of over-the-
counter drug and health food by school pharmacist for grade-schooler, 
junior high school student, and high school students. Yakugaku Zasshi 
131:835–842
Aoyama I, Koyama S, Hibino H (2012) Self-medication behaviors among Japa-
nese consumers: sex, age, and SES differences and caregivers’ attitudes 
toward their children’s health management. Asia Pac Fam Med 11:7
Bradley CP, Riaz A, Tobias RS, Kenkre JE, Dassu DY (1998) Patient attitudes to 
over-the-counter drugs and possible professional responses to self-
medication. Fam Pract 15:44–50
Conn VS (1991) Older adults: factors that predict the use of over-the-counter 
medication. J Adv Nurs 16:1190–1196
Eichenberg C, Auersperg F, Rusch BD, Brähler E (2015) Self-medication: a 
nationwide representative survey on motives, reasons and sources on 
consuming over-the-counter medication. Psychother Psychosom Med 
Psychol. 2015
Holtgräfe C, Zentes J (2012) Multifaceted determinants of online non-pre-
scription drug information seeking and the impact on consumers’ use of 
purchase channels. Health Informatics J 18:95–110
Kawase A, JeongSeo C, Koyama S, Izumisawa M, Hibino H (2012) Evaluation of 
package design for Over-The-Counter medicine by comparing Japanese 
and US consumer behavior. Available from URL: https://www.jstage.jst.
go.jp/article/jssd/59/0/59_95/_pdf. Accessed 9 July 2015
Morales-Suárez-Varela M, Llopis-González A, Caamaño-Isorna F, Gimeno-
Clemente N, Ruiz-Rojo E, Rojo-Moreno L (2009) Adolescents in Spain: use 
of medicines and adolescent lifestyles. Pharm World Sci 31:656–663
Mutebi A, Warholak TL, Hines LE, Plummer R, Malone DC (2013) Assessing 
patients’ information needs regarding drug-drug interactions. J Am 
Pharm Assoc 53:39–45
MyVoice Co., Inc. (2012) A survey on purchase of medical drugs. Available from 
URL: http://www.myvoice.co.jp/biz/surveys/16814/index.html. Accessed 
1 Aug 2015
Nakao H, Imai H, Sato H, Tsuchiya F (2015) A fact-finding consumer survey on 
the Internet purchasing of OTC medications. Available from URL: https://
research-er.jp/projects/view/918611. Accessed 18 Oct 2015
Nielsen MW, Hansen EH, Rasmussen NK (2003) Prescription and non-prescrip-
tion medicine use in Denmark: association with socio-economic position. 
Eur J Clin Pharmacol 59:677–684
Raynor D, Blenkinsopp A, Knapp P, Grime J, Nicolson D, Pollock K, Spoor P 
(2007) A systematic review of quantitative and qualitative research on the 
role and effectiveness of written information available to patients about 
individual medicines. Health Tech Assess 11:1–160
Sakurai H (2003) Healthy Japan 21. JMAJ 46:47–49
Sasaki K, Ohbayashi M, Kohyama N, Kobayashi Y, Yamamoto T (2008) Descrip-
tive study on the circumstances concerning confirmation of contrain-
dications and careful administration upon purchasing over-the-counter 
cold medication and manifestation of after-use urinary disorders. 
Yakugaku Zasshi 128:1301–1309
Sato K, Yamazaki S, Hayashino Y, Takegami M, Tokuda Y, Takahashi O, Shimbo 
T, Hinohara S, Fukui T, Fukuhara S (2011) Associations between hours 
Page 11 of 11Hayashi et al. SpringerPlus  (2015) 4:737 
worked, symptoms and health resource utilization among full-time male 
Japanese workers. J Occup Health 53:197–204
Shaku F, Tsutsumi M, Miyazawa A, Takagi H, Maeno T (2015) Self-care behavior 
when suffering from the common cold and health-related quality of life 
in individuals attending an annual checkup in Japan: a cross-sectional 
study. BMC Fam Pract 16:91
Tachi T, Teramachi H, Goto T (2015) The effect of education for patients at the 
time of discharge that are aimed at promoting management of the use 
of over-the-counter medicines and health foods by medicine pocket-
book system. Available from URL: http://www.otc-spf.jp/symposium/pdf/
h25b_02.pdf. Accessed 1 August 2015
The Ministry of Health, Labour and Welfare of Japan (1997) Survey on trends 
in health and welfare. Available from URL: http://www1.mhlw.go.jp/
toukei/h-fukusi/. Accessed 27 Apr 2015
The Ministry of Health, Labour and Welfare of Japan (2002a) Health Promotion 
Act 2002
The Ministry of Health, Labour and Welfare of Japan (2002b) Interim report on 
the expected roles of OTC medications in self-medication 2002
The Ministry of Health, Labour and Welfare of Japan (2007) New vision for the 
pharmaceutical industry
The Ministry of Health, Labour and Welfare of Japan (2015) Lifestyle related 
disease. Available from URL: http://www.e-healthnet.mhlw.go.jp/informa-
tion/dictionary/metabolic/ym-040.html. Accessed 27 Apr 2015
The World Health Organization (1998) The Role of the Pharmacist in Self-Care 
and Self-Medication
Tokyo metropolitan government (2011) Survey on over-the-counter medica-
tions among residents in Tokyo. Available from URL: http://www.metro.
tokyo.jp/INET/CHOUSA/2011/07/DATA/60l7p401.pdf. Accessed 14 Jul 
2015
Villako P, Volmer D, Raal A (2012) Factors influencing purchase of and counsel-
ling about prescription and OTC medicines at community pharmacies in 
Tallinn, Estonia. Acta Pol Pharm 9:335–340
Wazaify M, Shields E, Hughes MC, McElnay CJ (2005) Societal perspectives on 
over-the-counter (OTC) medicines. Fam Prac 22:170–176
